Ledger.Open graph →

SEC Form D · filed February 28, 2018

Flow Pharma, Inc

Offering

—

Sold

$1.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WALNUT CREEK, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Reid M. Rubsamen · Alamo, CAExec · Director Lester J. Lloyd · Orinda, CAExec · Director Sally W. Dodge · EVANSTON, ILExec · Director Andy W. Ambriole · EVANSTON, ILExec · Director Haim Dabah · New York, NYExec · Director Yok Hua R. Tek · Singapore, U0Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗